Disulfidptosis-related genes serve as potential prognostic biomarkers and indicate tumor microenvironment characteristics and immunotherapy response in prostate …

R Zhou, D Lu, J Mi, C Wang, W Lu, Z Wang, X Li… - Scientific Reports, 2024 - nature.com
Disulfidptosis, a newly identified programmed cell death pathway in prostate cancer (PCa),
is closely associated with intracellular disulfide stress and glycolysis. This study aims to …

Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control

RG Levin-Epstein, NY Jiang, X Wang… - Radiotherapy and …, 2021 - Elsevier
Background and purpose The optimal dose for prostate stereotactic body radiotherapy
(SBRT) is still unknown. This study evaluated the dose–response relationships for prostate …

EXTL3 could serve as a potential biomarker of prognosis and immunotherapy for prostate cancer and its potential mechanisms

P Chang, S Chen, X Chang, J Zhu, Q Tang… - European Journal of …, 2022 - Springer
Background Exostosin like glycosyltransferase 3 (EXTL3) had been reported to be
associated with immune deficiency and play prognostic roles in various cancers. However …

Translating the immunobiology of SBRT to novel therapeutic combinations for advanced prostate cancer

VR Adorno Febles, S Blacksburg, JA Haas… - Frontiers in …, 2020 - frontiersin.org
Stereotactic body radiotherapy (SBRT) is an increasingly used radiation modality for the
treatment of both localized and metastatic prostate cancer. Substantial data suggests that …

[HTML][HTML] Dose accumulation for personalized stereotactic MR-guided adaptive radiation therapy in prostate cancer

O Bohoudi, AME Bruynzeel, S Tetar, BJ Slotman… - Radiotherapy and …, 2021 - Elsevier
Background and purpose Adaptive MR-guided radiotherapy (MRgRT) is an innovative
approach for delivering stereotactic body radiotherapy (SBRT) in prostate cancer (PC) …

[HTML][HTML] Bowel and bladder reproducibility in image guided radiation therapy for prostate cancer: results of a patterns of practice survey

LS Rowe, JJ Mandia, KE Salerno… - Advances in radiation …, 2022 - Elsevier
Purpose Optimal management of patients with prostate cancer (PCa) to achieve bowel and
bladder reproducibility for radiation therapy (RT) and the appropriate planning target volume …

When Patience is a Failing: The Case for Patient Reported Outcomes Adoption

DW Bruner - International Journal of Radiation Oncology, Biology …, 2023 - redjournal.org
TaggedPPatience is supposed to be a virtue.... which I lack. Or maybe there are times when
patience is an excuse to wait when one is doing nothing or hoping someone else will do …

Simulating an intra-fraction adaptive workflow to enable PTV margin reduction in MRIgART volumetric modulated arc therapy for prostate SBRT

J Snyder, B Smith, JS Aubin, A Shepard… - Frontiers in oncology, 2024 - frontiersin.org
Purpose This study simulates a novel prostate SBRT intra-fraction re-optimization workflow
in MRIgART to account for prostate intra-fraction motion and evaluates the dosimetric benefit …

PVT1 Expression Is a Predictor for Poor Survival of Prostate Cancer Patients

J Liu, Y Li, Q Zhang, C Lv, M Wang… - … in Cancer Research …, 2021 - journals.sagepub.com
Objective: Dysregulation of long noncoding RNA is associated with a variety of cancers and
LncRNA has anticancer or carcinogenic activities. PVT1, as a long noncoding RNA, plays an …

Rectal radiation dose and clinical outcomes in prostate cancer patients treated with stereotactic body radiation therapy with and without hydrogel

P Kundu, EY Lin, SM Yoon, NR Parikh, D Ruan… - Frontiers in …, 2022 - frontiersin.org
Background Patients with prostate cancer treated with stereotactic body radiation therapy
(SBRT) may experience gastrointestinal (GI) toxicity. The hydrogel may mitigate this toxicity …